C4 Therapeutics, Inc. (CCCC)
NASDAQ: CCCC · Real-Time Price · USD
3.920
-0.140 (-3.45%)
At close: Jul 13, 2026, 4:00 PM EDT
3.900
-0.020 (-0.51%)
After-hours: Jul 13, 2026, 7:51 PM EDT
C4 Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $7 | Buy | Maintains | $7 | +78.57% | Jun 22, 2026 |
| Wells Fargo | Wells Fargo | Buy Reiterates $10 | Buy | Reiterates | $10 | +155.10% | May 13, 2026 |
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 12, 2026 |
| Jefferies | Jefferies | Buy Maintains $14 | Buy | Maintains | $14 | +257.14% | Apr 30, 2026 |
| Guggenheim | Guggenheim | Buy Reiterates $7 | Buy | Reiterates | $7 | +78.57% | Feb 27, 2026 |
| Brookline Capital Markets | Brookline Capital Markets | Buy Maintains $20 → $30 | Buy | Maintains | $20 → $30 | +665.31% | Feb 23, 2026 |